Page last updated: 2024-11-02

oxyphenbutazone and Retroperitoneal Fibrosis

oxyphenbutazone has been researched along with Retroperitoneal Fibrosis in 1 studies

Oxyphenbutazone: A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. (From AMA, Drug Evaluations Annual, 1994, p2000) It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p27)
oxyphenbutazone : A metabolite of phenylbutazone obtained by hydroxylation at position 4 of one of the phenyl rings. Commonly used (as its hydrate) to treat pain, swelling and stiffness associated with arthritis and gout, it was withdrawn from the market 1984 following association with blood dyscrasis and Stevens-Johnson syndrome.

Retroperitoneal Fibrosis: A slowly progressive condition of unknown etiology, characterized by deposition of fibrous tissue in the retroperitoneal space compressing the ureters, great vessels, bile duct, and other structures. When associated with abdominal aortic aneurysm, it may be called chronic periaortitis or inflammatory perianeurysmal fibrosis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lent, V1
Haferkamp, H1

Other Studies

1 other study available for oxyphenbutazone and Retroperitoneal Fibrosis

ArticleYear
[Therapy in idiopathic retroperitoneal fibrosis].
    Deutsche medizinische Wochenschrift (1946), 1973, Nov-09, Volume: 98, Issue:45

    Topics: Ergotamine; Glucocorticoids; Humans; Long-Term Care; Methods; Oxyphenbutazone; Prognosis; Retroperit

1973